Biotech · Private company
Emmecell
Track this companyFree. Adds Emmecell to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- 150K cellsPhase 2 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
- 500K cellsPhase 2 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
- EO2002Phase 1 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
- EO2002 high dosePhase 1 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
- EO2002 low dosePhase 1 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
- EO2002 mid dosePhase 1 · Corneal EdemaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial DysfunctionPHASE2 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07729137 · fetched Nov 12, 2026
- Study of Safety and Tolerability of EO2002 in the Treatment of Corneal EdemaPHASE1 · COMPLETED · started Jun 22, 2021ClinicalTrials.gov NCT04894110 · fetched Nov 12, 2026